Rephonic
Artwork for The BioCentury Show

The BioCentury Show

BioCentury
FDA
Biotechnology
Clinical Trials
Drug Pricing
Drug Development
China
Artificial Intelligence
Biotech
Biologics
Pharmaceutical Industry
Gene Therapy
Biosimilars
Inflation Reduction Act
Cancer Treatments
Novartis
Oncology
Mergers and Acquisitions
Immunology
Drug Regulation
Private Equity

Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine.

Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues.

The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how scien... more

PublishesTwice monthlyEpisodes74Founded2 years ago
Number of ListenersCategories
Life SciencesBusinessScience

Listen to this Podcast

Artwork for The BioCentury Show

Latest Episodes

Tigermed, the largest clinical CRO in China, has expanded into more than 50 countries and is growing its North American operations, offering full-service support from preclinical through Phase IV. On this sponsored edition of The BioCentury Show, Bri... more

YouTube

Arrowhead Pharmaceuticals can now deliver siRNA to seven cell types, and new data showing subcutaneous delivery to the brain could push RNAi therapies well beyond the liver. On this edition of The BioCentury Show, Arrowhead Chairman, President, and C... more

YouTube

Untapped multibillion-dollar markets are hiding in plain sight where patients endure mediocre generic standards of care, according to Canaan General Partner Julie Grant, co-founder and first CEO of Day One, which Servier acquired for $2.5 billion thi... more

YouTube

On this edition of The BioCentury Show, Nick Galakatos, Global Head of Life Sciences at Blackstone, joins Editor in Chief Simone Fishburn to discuss the path from Clarus to Blackstone's new $6.3 billion fund, and the goal of game-changing bets.

Galak... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Britney Winterberger
Vice president and head of North America clinical operations at Tigermed
Tigermed
Episode: Ep. 122 - Tigermed's Britney Winterberger's take on running trials in the U.S. and China
Chris Anzalone
Chairman, President and CEO of Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals
Episode: Ep. 121 - Arrowhead’s Chris Anzalone on the future of RNAi
Julie Grant
General Partner at Canaan, leads company formation and investment in biopharma
Canaan
Episode: Ep. 120 - Canaan’s Julie Grant on building biotechs in white spaces
Nick Galakatos
Global Head of Life Sciences at Blackstone; Chairman of its Investment Committees
Blackstone Life Sciences
Episode: Ep. 119 - Blackstone's Galakatos on funding biotech's hardest mile
Gonçalo Abecasis
Vice President and Chief Genomics and Data Sciences Officer, Regeneron Genetics Center
Regeneron
Episode: Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets
Klaus Romero
CEO and CSO of Critical Path Institute (C-Path)
Critical Path Institute
Episode: Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient
Jessica Owens
Partner at Initiate Ventures, AI-native healthcare investor and co-founder
Initiate Ventures
Episode: Ep. 115 - Initiate's Owens on what it takes to be AI-native
Frank Jiang
EVP and Chief Strategy Officer of Hengrui Pharmaceuticals
Hengrui Pharmaceuticals
Episode: Ep. 113 - Frank Jiang on Hengrui’s rise and China’s new era of biopharma dealmaking
Chris Arendt
Chief Scientific Officer at Takeda
Takeda
Episode: Ep. 112 - Chris Arendt on rebuilding Takeda for AI

Hosts

Jeff Cranmer
Executive Editor, BioCentury
Simone Fishburn
Host of The BioCentury Show
Selina Koch
Executive Editor at BioCentury

Reviews

4.7 out of 5 stars from 23 ratings
  • Wow

    Insightful and full of great info every time! Thx!

    Apple Podcasts
    5
    Surfrider182
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Insightful interviews with industry leaders and decision-makers.
High-quality guests but sometimes dense for newcomers.
Strong emphasis on translating science to patient impact and market strategy.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Ep. 121 - Arrowhead’s Chris Anzalone on the future of RNAi
Q: What are the biggest challenges that still face siRNA therapies in becoming a standard, widely used therapeutic?
Anzalone says the field needs time for more candidates to progress through clinical development and needs to improve delivery to more cell types. He highlights Arrowhead's early subcutaneous brain-delivery results as an example of progress beyond the liver.
Ep. 121 - Arrowhead’s Chris Anzalone on the future of RNAi
Q: What makes Arrowhead's approach to siRNA differentiated from other modalities?
Anzalone says the company's long experience and focus on delivering RNAi to multiple organ systems distinguish its platform. He argues siRNA offers durable, deep gene knockdown and safety advantages, while acknowledging that ASOs can enable exon skipping and reach cell types siRNA cannot yet access.
Ep. 122 - Tigermed's Britney Winterberger's take on running trials in the U.S. and China
Q: Can you talk a little bit about the value of running concurrent trials starting in China and the U.S. at the same time, and what the optimal sequence of trials across regions?
Winterberger recommends a combined U.S.-China protocol to reduce the risk of relying solely on China-generated data and to capture faster enrollment in China. Sponsors often start U.S. sites first, then add China sites, and discuss the strategy with the FDA in a pre-IND meeting.
Ep. 122 - Tigermed's Britney Winterberger's take on running trials in the U.S. and China
Q: How do you help U.S. sponsors run trials in China?
Tigermed helps sponsors navigate local regulations, hospitals, recruitment, genetic-sample restrictions, and laboratory requirements. China can offer large patient populations, faster enrollment, experienced investigators, and lower per-patient costs.
Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets
Q: Before we turn to computation at the Regeneron Genetics Center, how many genetic signals does the RGC generate in a year that make it toward drug development?
About a dozen new signals progress into the pipeline each year, with the team prioritizing the most compelling, well-supported signals and balancing the need to push forward with the risk of overloading development workflows.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The BioCentury Show

What is The BioCentury Show about and what kind of topics does it cover?

A deep, executive-level discussion at the intersection of biology, medicine, and biotech investing. Episodes frequently feature CMOs, CEOs, and senior editors analyzing how translational science moves from discovery to patient impact, with a strong emphasis on dealmaking, AI-enabled drug discovery, regulatory enviroments, pricing, and policy. The series often highlights regional dynamics (US, UK, Europe, China) and practical implications for building biotech pipelines, partnerships, and finance strategies. A standout is the recurring focus on creating translational ecosystems that accelerate patient access, from translational science models to large-scale data and AI-enabled platforms. The show is especially noteworthy for its access to bio... more

Where can I find podcast stats for The BioCentury Show?

Rephonic provides a wide range of podcast stats for The BioCentury Show. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The BioCentury Show and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The BioCentury Show get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The BioCentury Show, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The BioCentury Show?

Rephonic provides comprehensive predictive audience data for The BioCentury Show, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The BioCentury Show have?

To see how many followers or subscribers The BioCentury Show has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The BioCentury Show?

These podcasts share a similar audience with The BioCentury Show:

1. BioCentury This Week
2. Biotech Hangout
3. The Readout Loud
4. The Long Run with Luke Timmerman
5. Biotech 2050 Podcast

How many episodes of The BioCentury Show are there?

The BioCentury Show launched 2 years ago and published 74 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The BioCentury Show?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The BioCentury Show?

Rephonic pulls ratings and reviews for The BioCentury Show from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The BioCentury Show?

Rephonic provides full transcripts for episodes of The BioCentury Show. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The BioCentury Show?

Recent guests on The BioCentury Show include:

1. Britney Winterberger
2. Chris Anzalone
3. Julie Grant
4. Nick Galakatos
5. Gonçalo Abecasis
6. Klaus Romero
7. Jessica Owens
8. Frank Jiang

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days